ramblings please clyde, page-5

the only people buying in are the people on hot copper...nobody else seems to know/remember this stock.

EMS needs a good deal of publicity. That's what is really needed to get things moving along.

I can't believe a pharmaceutical drug that has completed Phase III trials, with such a huge potential market (and arguably less risky drug than others) is still largely unknown.

I checked the EMS website and read through the news articles on ArTiMist back in 2008. They make for great reading, especially the article by Nick Evans.